Investigations into the mixed muscle–secretory phenotype of cardiomyocytes from the atrial
appendages of the heart led to the discovery that these cells produce, in a regulated …

The function of the right ventricle determines the fate of patients with pulmonary
hypertension. Since right heart failure is the consequence of increased afterload, a full …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …

Compared with traditional exercise tests, cardiopulmonary exercise testing (CPET) provides
a thorough assessment of exercise integrative physiology involving the pulmonary …

Background: Diagnosis of heart failure with preserved ejection fraction (HFpEF) is
challenging and relies largely on demonstration of elevated cardiac filling pressures …

Pulmonary arterial hypertension (PAH) is a rare dyspnoea-fatigue syndrome caused by a
progressive increase in pulmonary vascular resistance and eventual right ventricular (RV) …

Research in the last decade has substantially advanced our understanding of the
pathophysiology of heart failure with preserved ejection fraction (HFpEF). However …

Exercise intolerance, indicated by dyspnea and fatigue during exertion, is a cardinal
manifestation of heart failure (HF). Cardiopulmonary exercise testing (CPET) precisely …

The diagnosis and management of pulmonary arterial hypertension (PAH) includes several
advances, such as a broader recognition of extrapulmonary vascular organ system …